全文获取类型
收费全文 | 1401篇 |
免费 | 114篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 24篇 |
妇产科学 | 36篇 |
基础医学 | 158篇 |
口腔科学 | 17篇 |
临床医学 | 158篇 |
内科学 | 305篇 |
皮肤病学 | 7篇 |
神经病学 | 106篇 |
特种医学 | 102篇 |
外科学 | 95篇 |
综合类 | 45篇 |
预防医学 | 238篇 |
眼科学 | 22篇 |
药学 | 77篇 |
肿瘤学 | 125篇 |
出版年
2022年 | 12篇 |
2021年 | 24篇 |
2019年 | 18篇 |
2018年 | 15篇 |
2017年 | 12篇 |
2016年 | 17篇 |
2015年 | 30篇 |
2014年 | 36篇 |
2013年 | 42篇 |
2012年 | 62篇 |
2011年 | 55篇 |
2010年 | 43篇 |
2009年 | 43篇 |
2008年 | 84篇 |
2007年 | 75篇 |
2006年 | 54篇 |
2005年 | 44篇 |
2004年 | 45篇 |
2003年 | 35篇 |
2002年 | 45篇 |
2001年 | 27篇 |
2000年 | 36篇 |
1999年 | 35篇 |
1998年 | 28篇 |
1997年 | 36篇 |
1996年 | 29篇 |
1995年 | 24篇 |
1994年 | 21篇 |
1993年 | 17篇 |
1992年 | 23篇 |
1991年 | 24篇 |
1990年 | 25篇 |
1989年 | 33篇 |
1988年 | 24篇 |
1987年 | 20篇 |
1986年 | 24篇 |
1985年 | 28篇 |
1984年 | 25篇 |
1983年 | 12篇 |
1982年 | 13篇 |
1981年 | 13篇 |
1980年 | 18篇 |
1979年 | 13篇 |
1978年 | 16篇 |
1976年 | 16篇 |
1975年 | 12篇 |
1973年 | 13篇 |
1970年 | 13篇 |
1968年 | 12篇 |
1967年 | 12篇 |
排序方式: 共有1524条查询结果,搜索用时 15 毫秒
21.
22.
Johnson DE Slatkine M Cromeens DC Mead D Konwitz E 《Journal of clinical laser medicine & surgery》1993,11(5):243-245
We describe here a highly durable 600-mu optical fiber with a 20-mm frosted distal tip protected by a smooth transparent cover that is capable of remaining in contact with tissue for prolonged periods. When used with a neodymium:YAG (Nd:YAG) laser, the active fiber surface diffuses optical radiation in a radial pattern, delivering up to 40 W power, and thus providing consistent and uniform interstitial photothermal therapy. Preliminary animal studies have demonstrated the feasibility of using these fibers to treat a variety of soft-tissue tumors, including benign prostatic hyperplasia. 相似文献
23.
Seven PCA infusion pumps from seven manufacturers were evaluated. The condition for acceptable use of most of the units is that they not be used at low volumes that could result in overinfusion from the stored volume when an occlusion is cleared. All pumps met most accuracy, electrical safety, and performance criteria. Purchasing decisions should also take into consideration the cost of disposables, application, and medication security. 相似文献
24.
25.
26.
Leeanne J Mead Mark A Jenkins Joanne Young Simon G Royce Letitia Smith D James B St John Finlay Macrae Graham G Giles John L Hopper Melissa C Southey 《Clinical cancer research》2007,13(10):2865-2869
PURPOSE: Microsatellite instability (MSI) testing of colorectal cancer tumors is used as a screening tool to identify patients most likely to be mismatch repair (MMR) gene mutation carriers. We wanted to examine which microsatellite markers currently used to detect MSI best predict early-onset colorectal cancer caused by germ-line mutations in MMR genes. EXPERIMENTAL DESIGN: Invasive primary tumors from a population-based sample of 107 cases of colorectal cancer diagnosed before age 45 years and tested for germ-line mutations in MLH1, MSH2, MSH6, and PMS2 and MMR protein expression were screened for MSI using the National Cancer Institute panel and an expanded 10-microsatellite marker panel. RESULTS: The National Cancer Institute five-marker panel system scored 31 (29%) as (NCI)MSI-High, 13 (12%) as (NCI)MSI-Low, and 63 (59%) as (NCI)MS-Stable. The 10-marker panel classified 18 (17%) as (10)MSI-High, 17 (16%) as (10)MSI-Low, and 72 (67%) as (10)MS-Stable. Of the 26 cancers that lacked the expression of at least one MMR gene, 24 (92%) were positive for some level of MSI (using either microsatellite panel). The mononucleotide repeats Bat26, Bat40, and Myb were unstable in all (10)MSI-High cancers and all MLH1 and MSH2 mutation carriers (100% sensitive). Bat40 and Bat25 were unstable in all tumors of MSH6 mutation carriers (100% sensitive). Bat40 was unstable in all MMR gene mutation carriers (100% sensitive). By incorporating seven mononucleotide repeats markers into the 10-marker panel, we were able to distinguish the carriers of MSH6 mutations (all scored (10)MSI-Low) from the MLH1 and MSH2 mutation carriers (all scored (10)MSI-High). CONCLUSIONS: In early-onset colorectal cancer, a microsatellite panel containing a high proportion of mononuclear repeats can distinguish between tumors caused by MLH1 and MSH2 mutations from those caused by MSH6 mutations. 相似文献
27.
Leah A. Irish Michael P. Mead Li Cao Allison C. Veronda Ross D. Crosby 《Journal of sleep research》2021,30(1):e13048
Caffeine is the most widely used psychoactive substance in the world and is known to disrupt healthy sleep. However, very few studies have directly tested the effect of caffeine abstinence on sleep, and these have yielded inconsistent findings. The purpose of the present study was to examine changes in sleep following caffeine abstinence and examine the extent to which characteristics of habitual caffeine use moderated this change. Participants included 66 healthy, young adults with habitual caffeine use and poor sleep. During the 2‐week baseline, sleep was assessed using wrist actigraphy and daily caffeine use was assessed with bedtime diaries. Eligible participants then completed 1 week of caffeine abstinence, during which sleep was measured with wrist actigraphy. Multilevel models found no significant differences between either mean levels or growth trajectories of total sleep time or sleep efficiency between baseline and caffeine abstinence. Mean levels of sleep onset latency also did not differ between baseline and caffeine abstinence. A small but significant quadratic effect was observed, such that sleep onset latency decreased during the first few days of caffeine abstinence, then increased to levels above baseline. Characteristics of caffeine use did not moderate changes in sleep between baseline and caffeine abstinence. These data suggest that abstaining from caffeine may not result in long‐term sleep improvement for habitual caffeine users, which contradicts the common sleep health recommendation. The present findings encourage more rigorous investigation of the effectiveness of caffeine restriction on sleep. 相似文献
28.
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood 总被引:48,自引:5,他引:48
Ingram DA Mead LE Tanaka H Meade V Fenoglio A Mortell K Pollok K Ferkowicz MJ Gilley D Yoder MC 《Blood》2004,104(9):2752-2760
Emerging evidence to support the use of endothelial progenitor cells (EPCs) for angiogenic therapies or as biomarkers to assess cardiovascular disease risk and progression is compelling. However, there is no uniform definition of an EPC, which makes interpretation of these studies difficult. Although hallmarks of stem and progenitor cells are their ability to proliferate and to give rise to functional progeny, EPCs are primarily defined by the expression of cell-surface antigens. Here, using adult peripheral and umbilical cord blood, we describe an approach that identifies a novel hierarchy of EPCs based on their clonogenic and proliferative potential, analogous to the hematopoietic cell system. In fact, some EPCs form replatable colonies when deposited at the single-cell level. Using this approach, we also identify a previously unrecognized population of EPCs in cord blood that can achieve at least 100 population doublings, replate into at least secondary and tertiary colonies, and retain high levels of telomerase activity. Thus, these studies describe a clonogenic method to define a hierarchy of EPCs based on their proliferative potential, and they identify a unique population of high proliferative potential-endothelial colony-forming cells (HPP-ECFCs) in human umbilical cord blood. 相似文献
29.
30.